TRELLUS HEALTH LS -0006 (85Q) - Net Assets
Based on the latest financial reports, TRELLUS HEALTH LS -0006 (85Q) has net assets worth €8.71 Million EUR (≈ $10.18 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.22 Million ≈ $10.78 Million USD) and total liabilities (€513.00K ≈ $599.75K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read TRELLUS HEALTH LS -0006 (85Q) total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €8.71 Million |
| % of Total Assets | 94.44% |
| Annual Growth Rate | -30.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.16 |
TRELLUS HEALTH LS -0006 - Net Assets Trend (2021–2024)
This chart illustrates how TRELLUS HEALTH LS -0006's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of TRELLUS HEALTH LS -0006 for the complete picture of this company's asset base.
Annual Net Assets for TRELLUS HEALTH LS -0006 (2021–2024)
The table below shows the annual net assets of TRELLUS HEALTH LS -0006 from 2021 to 2024. For live valuation and market cap data, see 85Q stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €11.77 Million ≈ $13.76 Million |
-39.66% |
| 2023-12-31 | €19.50 Million ≈ $22.80 Million |
-22.28% |
| 2022-12-31 | €25.09 Million ≈ $29.34 Million |
-28.87% |
| 2021-12-31 | €35.27 Million ≈ $41.24 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to TRELLUS HEALTH LS -0006's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2293100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €41.36 Million | 351.51% |
| Total Equity | €11.77 Million | 100.00% |
TRELLUS HEALTH LS -0006 Competitors by Market Cap
The table below lists competitors of TRELLUS HEALTH LS -0006 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OPG Power Venture Plc
LSE:OPG
|
$162.26K |
|
Lipigon Pharmaceuticals AB
ST:LPGO
|
$163.02K |
|
Kingswood Holdings Ltd
LSE:KWG
|
$164.47K |
|
SysGroup PLC
LSE:SYS
|
$165.40K |
|
aReit Prop Ltd
JSE:APO
|
$158.90K |
|
Cordel Group PLC
LSE:CRDL
|
$158.36K |
|
MOBILITYONE LTD LS -025
F:31M
|
$158.28K |
|
Enlightify Inc.
NYSE:ENFY
|
$157.69K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TRELLUS HEALTH LS -0006's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 19,501,000 to 11,767,000, a change of -7,734,000 (-39.7%).
- Net loss of 7,782,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-7.78 Million | -66.13% |
| Other Changes | €48.00K | +0.41% |
| Total Change | €- | -39.66% |
Book Value vs Market Value Analysis
This analysis compares TRELLUS HEALTH LS -0006's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.22 | €0.00 | x |
| 2022-12-31 | €0.16 | €0.00 | x |
| 2023-12-31 | €0.12 | €0.00 | x |
| 2024-12-31 | €0.07 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TRELLUS HEALTH LS -0006 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -66.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6826.32%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.03x
- Recent ROE (-66.13%) is below the historical average (-37.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -16.73% | -23608.00% | 0.00x | 1.04x | €-9.43 Million |
| 2022 | -35.11% | -48944.44% | 0.00x | 1.03x | €-11.32 Million |
| 2023 | -32.51% | -33363.16% | 0.00x | 1.04x | €-8.29 Million |
| 2024 | -66.13% | -6826.32% | 0.01x | 1.03x | €-8.96 Million |
Industry Comparison
This section compares TRELLUS HEALTH LS -0006's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $36,612,343
- Average return on equity (ROE) among peers: -598.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TRELLUS HEALTH LS -0006 (85Q) | €8.71 Million | -16.73% | 0.06x | $159.96K |
| CERTIVE SOLUTIONS INC. (5CE) | $-10.47 Million | 0.00% | 0.00x | $296.62K |
| IQ-AI LTD. LS -01 (5Y1) | $707.07K | -72.35% | 0.70x | $144.21K |
| NIGHTINGALE HEALTH EO 1 (7XE) | $97.36 Million | -18.57% | 0.10x | $47.63 Million |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $295.66K | -4766.19% | 10.32x | $916.43K |
| DocCheck AG (AJ91) | $18.82 Million | 3.55% | 0.15x | $58.35 Million |
| CompuGroup Medical SE & Co. KGaA (COP) | $28.87 Million | 34.15% | 3.77x | $1.17 Billion |
| MeVis Medical Solutions AG (M3V) | $33.73 Million | 19.97% | 0.35x | $45.14 Million |
| Nexus AG (NXU) | $123.58 Million | 12.07% | 0.81x | $1.24 Billion |
About TRELLUS HEALTH LS -0006
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more